EGFR and glioblastoma: Mechanistically, this combination remodels tumor-cell lipid metabolism and downregulates fatty acid synthesis genes in an NF-κB-dependent manner, highlighting a promising therapeutic strategy for EGFR-overexpressed or mutated glioblastoma [91].